Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system

Gastroenterology

Volumn 148, Issue 7, 2015, Pages 1353-1361.e3

  Goldberg, David S ^a,b   Forde, Kimberly A ^a,b   Carbonari, Dena M ^a,b   Lewis, James D ^a,b   Leidl, Kimberly B F ^a   Reddy, K Rajender ^a   Haynes, Kevin ^a,b,c   Roy, Jason ^a,b   Sha, Daohang ^a   Marks, Amy R ^d   Schneider, Jennifer L ^d   Strom, Brian L ^a,b,e   Corley, Douglas A ^d   Lo Re, Vincent ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HEALTHCORE INC   (United States)

^d DIVISION OF RESEARCH   (United States)

^e UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Acetaminophen; Acute Liver Failure; Drug Induced Liver Injury

Indexed keywords

ALANINE AMINOTRANSFERASE; AMOXICILLIN PLUS CLAVULANIC ACID; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BUTALBITAL; CAFFEINE; CHINESE DRUG; CYTARABINE; DEXTROPROPOXYPHENE PLUS PARACETAMOL; ERYTHROMYCIN; HERBACEOUS AGENT; IBUPROFEN; IDARUBICIN; IMATINIB; ISONIAZID; LAMIVUDINE; LEFLUNOMIDE; LOSARTAN; METFORMIN; MEVINOLIN; NICOTINIC ACID; PANTOPRAZOLE; PARACETAMOL; RISPERIDONE; SIMVASTATIN; TENOFOVIR; TETRAHYDROLIPSTATIN; TRAMADOL; VALPROIC ACID; ZIDOVUDINE; NON PRESCRIPTION DRUG; PLANT MEDICINAL PRODUCT;

ACUTE LIVER FAILURE; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; DRUG INDUCED DISEASE; FEMALE; HEALTH CARE SYSTEM; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INCIDENCE; INTEGRATED HEALTH CARE SYSTEM; INTERNATIONAL NORMALIZED RATIO; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; VERY ELDERLY; YOUNG ADULT; ADVERSE EFFECTS; DIET SUPPLEMENTATION; DRUG-INDUCED LIVER INJURY; FACTUAL DATABASE; LIVER FAILURE, ACUTE; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TIME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CALIFORNIA; DATABASES, FACTUAL; DELIVERY OF HEALTH CARE, INTEGRATED; DIETARY SUPPLEMENTS; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; INCIDENCE; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; NONPRESCRIPTION DRUGS; PLANT PREPARATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84930014294     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.02.050     Document Type: Article

References (60)

1. W.M. Lee Acute liver failure in the United States Semin Liver Dis 23 2003 217 226
2. J.G. O'Grady, S.W. Schalm, and R. Williams Acute liver failure: redefining the syndromes Lancet 342 1993 273 275
3. G. Ostapowicz, R.J. Fontana, and F.V. Schiodt Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States Ann Intern Med 137 2002 947 954
4. W.M. Lee Drug-induced hepatotoxicity N Engl J Med 349 2003 474 485
5. A. Reuben, D.G. Koch, and W.M. Lee Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study Hepatology 52 2010 2065 2076
6. N. Chalasani, R. Vuppalanchi, and V. Navarro Acute liver injury due to flavocoxid (Limbrel), a medical food for osteoarthritis: a case series Ann Intern Med 156 2012 857 860 W297-W300
7. L.M. Forman, D.A. Simmons, and R.H. Diamond Hepatic failure in a patient taking rosiglitazone Ann Intern Med 132 2000 118 121
8. L. Laine, L. Goldkind, and S.P. Curtis How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial Am J Gastroenterol 104 2009 356 362
9. A.M. Larson, J. Polson, and R.J. Fontana Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study Hepatology 42 2005 1364 1372
10. R. Vuppalanchi, P.H. Hayashi, and N. Chalasani Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network Aliment Pharmacol Ther 32 2010 1174 1183
11. W.A. Bower, M. Johns, and H.S. Margolis Population-based surveillance for acute liver failure Am J Gastroenterol 102 2007 2459 2463
12. A. Escorsell, A. Mas, and M. de la Mata Spanish Group for the Study of Acute Liver Failure. Acute liver failure in Spain: analysis of 267 cases Liver Transpl 13 2007 1389 1395
13. J. Hadem, F. Tacke, and T. Bruns Etiologies and outcomes of acute liver failure in Germany Clin Gastroenterol Hepatol 10 2012 664 669 e662
14. F.V. Schiodt, E. Atillasoy, and A.O. Shakil Etiology and outcome for 295 patients with acute liver failure in the United States Liver Transpl Surg 5 1999 29 34
15. R.J. Andrade, M.I. Lucena, and M.C. Fernandez Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish Registry over a 10-year period Gastroenterology 129 2005 512 521
16. E. Bjornsson, and R. Olsson Outcome and prognostic markers in severe drug-induced liver disease Hepatology 42 2005 481 489
17. V.J. Navarro, H. Barnhart, and H.L. Bonkovsky Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network Hepatology 60 2014 1399 1408
18. Liver Toxicity Knowledge Base (LTKB). Available: http://www.fda.gov/ScienceResearch/BioinformaticsTools/LiverToxicityKnowledgeBase/ucm2024036.htm. Accessed: January 13, 2015.
19. J.H. Hoofnagle, J. Serrano, J.E. Knoben, and V.J. Navarro LiverTox: a website on drug-induced liver injury Hepatology 57 2013 873 874
20. J.R. Senior Drug hepatotoxicity from a regulatory perspective Clin Liver Dis 11 2007 507 524 vi
21. G. Friedman, L. Habel, and M. Boles Kaiser Permanente Medical Care Program: Division of Research, Northern California, and Center for Health Research, Northwest Division B.L. Strom, Pharmacoepidemiology 3rd ed. 2000 John Wiley & Sons, Ltd West Sussex 263 283
22. C. Koebnick, A.M. Langer-Gould, and M.K. Gould Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data Perm J 16 2012 37 41
23. Gordon NP. How does the adult Kaiser Permanente membership in Northern California compare with the larger community? 2006. Available: http://www.dor.kaiser.org/external/uploadedFiles/content/research/mhs/-2011-Revised-Site/Documents-Special-Reports/comparison-kaiser-vs-nonKaiser-adults-kpnc(1).pdf. Accessed: December 23, 2013.
24. M. Schatz, R.S. Zeiger, and W.M. Vollmer Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data J Allergy Clin Immunol 117 2006 995 1000
25. K. Jinjuvadia, W. Kwan, and R.J. Fontana Searching for a needle in a haystack: use of ICD-9-CM codes in drug-induced liver injury Am J Gastroenterol 102 2007 2437 2443
26. R.P. Myers, Y. Leung, and A.A. Shaheen Validation of ICD-9-CM/ICD-10 coding algorithms for the identification of patients with acetaminophen overdose and hepatotoxicity using administrative data BMC Health Serv Res 7 2007 159
27. V. Lo Re 3rd, K. Haynes, and D. Goldberg Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed Database Pharmacoepidemiol Drug Saf 22 2013 861 872
28. M. Robles-Diaz, M.I. Lucena, and N. Kaplowitz Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury Gastroenterology 147 2014 109 118 e105
29. J. Polson, and W.M. Lee AASLD position paper: the management of acute liver failure Hepatology 41 2005 1179 1197
30. OPTN/UNOS Policy 3.7.B: Required expedited modifications of waiting time. Available: http://optn.transplant.hrsa.gov/ContentDocuments/OPTN-Policies.pdf. Accessed: October 2, 2014.
31. G.P. Aithal, P.B. Watkins, and R.J. Andrade Case definition and phenotype standardization in drug-induced liver injury Clin Pharmacol Ther 89 2011 806 815
32. F. Alvarez, P.A. Berg, and F.B. Bianchi International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 1999 929 938
33. M.P. Manns, A.J. Czaja, and J.D. Gorham Diagnosis and management of autoimmune hepatitis Hepatology 51 2010 2193 2213
34. D. Vergani, F. Alvarez, and F.B. Bianchi Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group J Hepatol 41 2004 677 683
35. R.J. Fontana, P.B. Watkins, and H.L. Bonkovsky Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct Drug Saf 32 2009 55 68
36. D.C. Rockey, L.B. Seeff, and J. Rochon Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method Hepatology 51 2010 2117 2126
37. G. Danan, and C. Benichou Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries J Clin Epidemiol 46 1993 1323 1330
38. C. Benichou, G. Danan, and A. Flahault Causality assessment of adverse reactions to drugs-II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge J Clin Epidemiol 46 1993 1331 1336
39. M. Garcia-Cortes, C. Stephens, and M.I. Lucena Spanish Group for the Study of Drug-Induced Liver Disease. Causality assessment methods in drug induced liver injury: strengths and weaknesses J Hepatol 55 2011 683 691
40. S.H. Preston, P. Heuveline, and M. Guillot Demography: measuring and modeling population processes 2001 Blackwell Publishers Oxford, UK
41. Centers for Disease Control and Prevention: therapeutic drug use. Available: http://www.cdc.gov/nchs/fastats/drugs.htm. Accessed: November 15, 2013.
42. C.M. Wilcox, B. Cryer, and G. Triadafilopoulos Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs J Rheumatol 32 2005 2218 2224
43. R.L. Bailey, J.J. Gahche, and C.V. Lentino Dietary supplement use in the United States, 2003-2006 J Nutr 141 2011 261 266
44. M. Mendizabal, S. Marciano, and M.G. Videla Changing etiologies and outcomes of acute liver failure: perspectives from 6 transplant centers in Argentina Liver Transpl 20 2014 483 489
45. U.S. Food and Drug Administration: dietary supplements. Available: http://www.fda.gov/food/dietarysupplements/. Accessed: November 18, 2013.
46. K. Hawton, S. Simkin, and J. Deeks UK legislation on analgesic packs: before and after study of long term effect on poisonings BMJ 329 2004 1076
47. E.S. Bjornsson, O.M. Bergmann, and H.K. Bjornsson Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland Gastroenterology 144 2013 1419 1425 1425 e1411-e1413; quiz e1419-e1420
48. M. Thiim, and L.S. Friedman Hepatotoxicity of antibiotics and antifungals Clin Liver Dis 7 2003 381 399 vi-vii
49. K.L. Nash, T.M. Yeung, and P.J. Lehner Orthotopic liver transplantation for subacute hepatic failure following partial treatment of isoniazid-resistant tuberculosis Transpl Infect Dis 10 2008 272 275
50. T. Hasagawa, J. Reyes, and B. Nour Successful liver transplantation for isoniazid-induced hepatic failure-a case report Transplantation 57 1994 1274 1277
51. F.J. Farrell, E.B. Keeffe, and K.M. Man Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation Dig Dis Sci 39 1994 2255 2259
52. S.E. Bilasy, S.S. Essawy, and M.F. Mandour Myelosuppressive and hepatotoxic potential of leflunomide and methotrexate combination in a rat model of rheumatoid arthritis Pharmacol Rep 67 2015 102 114
53. J.H. Kong, S.H. Yoo, and K.E. Lee Early imatinib-mesylate-induced hepatotoxicity in chronic myelogenous leukaemia Acta Haematol 118 2007 205 208
54. J. Floyd, I. Mirza, and B. Sachs Hepatotoxicity of chemotherapy Semin Oncol 33 2006 50 67
55. Y.T. Tseng, C.J. Yang, and S.Y. Chang Incidence and risk factors of skin rashes and hepatotoxicity in HIV-infected patients receiving nevirapine-containing combination antiretroviral therapy in Taiwan Int J Infect Dis 29 2014 12 17
56. W. Mulu, B. Gidey, and A. Chernet Hepatotoxicity and associated risk factors in HIV-infected patients receiving antiretroviral therapy at Felege Hiwot Referral Hospital, Bahirdar, Ethiopia Ethiop J Health Sci 23 2013 217 226
57. M. Vogel, and J.K. Rockstroh Hepatotoxicity and liver disease in the context of HIV therapy Curr Opin HIV AIDS 2 2007 306 313
58. W.M. Lee, R.H. Squires Jr., and S.L. Nyberg Acute liver failure: summary of a workshop Hepatology 47 2008 1401 1415
59. V.J. Navarro, and J.R. Senior Drug-related hepatotoxicity N Engl J Med 354 2006 731 739
60. M.W. Russo, J.A. Galanko, and R. Shrestha Liver transplantation for acute liver failure from drug induced liver injury in the United States Liver Transpl 10 2004 1018 1023